Invitation to participate in an open consultation for the Strategic Research and Innovation Agenda (SRIA) in support for the European Partnership for Personalised Medicine, EP PerMed

It is our pleasure to inform you that the open consultation to validate and receive input for the Strategic Research and Innovation Agenda (SRIA) in support for the European Partnership for Personalised Medicine, EP PerMed, is launched. The outcome of the online consultation will be considered for the SRIA finalisation (02/2023) and the EP PerMed proposal (04/2023) as well as for developing activities and calls within the EP PerMed lifetime (Q4/2023-2030).

In preparation of the open consultation, the drafting group, with support of the European Commission, conducted almost 70 interviews with diverse stakeholders. Based on the interviews and consultation of strategic documents, a first set of 47 “Triplets of Action” was identified (further defined below). This list represents a first summary, adapted to a common format, but is not exhaustive and open for further input and refinement.

In a pre-final step (November 2022), the drafting group performs now an online consultation for the following purposes:

  • Communication of the SRIA in general and the identified “Triplets of Action” in specific,
  • To obtain general input, especially related to the “Triplets of Action”,
  • Input regarding the urgency and timing of the “Triplets of Action”,
  • To obtain suggestions for additional “Triplets of Action”.

The questionnaire will take around 30 min to be completed. The open consultation will close on 21 December 2022 and can be accessed through this link: http://enquetes.agencerecherche.fr/index.php/survey/index/sid/976696/lang/en

 

More information is available on the ICPerMed (https://www.icpermed.eu/en/EP-PerMed-SRIA-Consultation.php) and ERA PerMed websites and provided at the end of this email.

We would be pleased about your participation in this open consultation.

Please share this information with your colleagues and other stakeholders that might contribute with their expertise to the EP PerMed SRIA.

For any question you might have regarding the EP PerMed and the SRIA, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..

 

Background information:

European Partnership for Personalised Medicine (EP PerMed)

The EP PerMed is one of the European research and innovation partnerships under Horizon Europe which will be dedicated to maximising the benefits of personalised medicine (PM) approaches. The European Commission and Member States have made large investments in personalised medicine over the years and this partnership builds on many of these investments. The core of the partnership is to invest in multidisciplinary, transnational research (basic, clinical, and translational) and innovation activities that will build and disseminate new knowledge, develop new technologies and methods, as well as supporting testing and piloting of the implementation of PM approaches. The partnership will work in close collaboration with other health partnerships and reach out to national, regional, and international initiatives and frameworks to ensure synergies and investments of scale. In addition, the partnership will include supportive activities contributing to policy, regulation and strengthening the field of health economics. Early this year, a draft proposal was published. At present the consortium is formed to draft the proposal for submission to the EC in April 2023. The investments from both Member States and the Commission for the 7-10 years duration of the partnership is expected to be over 300 Mio. Euros.

The EP PerMed Strategic Research and Innovation Agenda (SRIA), which is currently in preparation will guide the funding and supporting activities.

Strategic Research and Innovation Agenda (SRIA) to support the EP PerMed

All European Partnerships (EP) develop a SRIA before their launch to ensure that their long-term vision is translated into tailored roadmaps with activities, objectives and measurable outcomes.

The EP PerMed SRIA presents gaps, needs and challenges which should be addressed to maximise the benefits of Personalised Medicine approaches and ensure that there is an equal access to these approaches. The SRIA is divided into four areas of activities, “interdisciplinary research including basic, translational and clinical”, “innovation system” and “implementation” as well as “Overarching activities”. The consortium together with international experts and stakeholders have collected input and analysed reports. The drafting group, with kind support of the European Commission, organised almost 70 interviews with a diverse set of stakeholders. The interviews were translated into Triplets of Action (further explained below), where applicable.

A key element of the SRIA are the so-called Triplets of Action (challenge/objective/outcome) related to personalised medicine. The challenge/objective/outcome sequence allows to specify gaps, needs and actions in a structured and comparable way, following this definition:

Challenge:           Description of the status quo, indicate/indication what is still lacking, why this is the case and what negative consequences this has.

Objectives:          Indicates what exactly should be done to address the challenge in terms of specific actions.

Outcome:            Description of how the situation will have improved once the actions described in the objectives have been successfully implemented. 

The Triplets of Action will give an overview of needs and gaps and guide the prioritisation of challenges and subsequent actions. So far, over the different areas and chapters of the SRIA a total of 47 Triplets of Action were identified. This list is not exhaustive and open for further input and refinement.

By taking part in the open consultation launched in November 2022, participants can share their view on future activities and research for accelerating the implementation of personalised medicine approaches. Input from the whole spectrum of stakeholders and experts involved in the personalised medicine areas is encouraged, such as scientists, healthcare professionals, patients, citizens, policy advisors or individuals working in the pharma industry and biotech.

ISIDORe preparedness calls for proposals

Monday, 28 November 2022 11:12

ISIDORe preparedness calls for proposals

Following its rapid research response calls for proposals dedicated to SARS-CoV-2  (still open) and Monkeypox virus (Pre-application deadline: 29 November 2022), ISIDORe (Integrated Services for Infectious Disease Outbreak Research) has launched its preparedness programme calls for proposals for free of charge access to the consortium facilities and services.

To prevent future pandemics, and advance the development of the appropriate medical countermeasures, the ISIDORe preparedness programme includes a list of priority preparedness pathogens clustered in four calls for proposals to support research on the epidemic-prone pathogens such as Risk-Group 4 pathogens (Ebola virus, Marburg virus, Nipah virus, Hendra virus, Lassa virus, “New world arenaviruses”, CCHF virus); Respiratory Pathogens (zoonotic betacoronaviruses, Influenza A, Y. Pestis, M. Tuberculosis/bovis, C. burnetii ); Vector-borne Pathogens (Rift valley fever virus, Zika virus, Chikungunya virus, West Nile virus, Dengue virus, Japanese encephalitis virus, Yellow fever virus, Tick-borne encephalitis virus, Plasmodium, B. burgdorferi, Leishmania); and other pathogens with epidemic potential (pathogen X, Orthopoxviruses, Non polio enteroviruses, Polio enteroviruses).

More information about the calls and how to apply can be found here

 

ISIDORe Information webinar

29 November, 2022, 10AM CET

The ISIDORe coordination team is pleased to invite you to the Information Webinar dedicated to the Preparedness calls for proposals (RG4 pathogens, Respiratory pathogens, Vector-borne pathogens, Pathogen X) launched in November 2022. It aims to provide you with information about the calls and application modalities, as well as to answer your questions.

Register here

More information can be found here


 

 

The International Union of Pure and Applied Chemistry is the global organization that provides objective scientific expertise and develops the essential tools for the application and communication of chemical knowledge for the benefit of humankind and the world. In 2019 IUPAC entered its second century, providing an opportunity to launch initiatives to create a more diverse and inclusive community. This webinar offers an overview, some insights and progress on this journey, with a focus on gender issues.

The event will be held online on October 26th, 2022 at 2-4 PM CEST.

More infos on the webinar and registration form: https://gender-equality-in-science.org/event/scges-webinar-october-26th-2022/

 

Participants in the webinar:

Laura McConnell, Bayer Crop Science, Bayer Science Fellow, Regulatory Scientific Affairs, United States
“Building A Global Network”

Mary Garson, Professor, School of Chemistry and Molecular Biosciences, The University of Queensland, Australia
“Expanding the Role of Women in IUPAC”

Mei-Hung Chiu, Professor, National Taiwan Normal University, Graduate Institute of Science Education
“Nurturing a more inclusive STEM Community”

Discussion moderated by Mark Cesa, President of IUPAC, 2014-15.

 

New ÖGMBT company member

Monday, 03 October 2022 02:01

We welcome our new ÖGMBT Company Member: Ludwig Boltzmann Gesellschaft Career Center (LBG-CC)

 

 LBG Career Center – We care for Pre- & Post-Docs

We support (young) researchers in Austria in achieving their individual career goals – in or outside of academia. Contact us for a career chat, join our workshops or special programs and design your own unique career path! We empower you to enhance your knowledge and skills for your next career steps and to expand your network. Apply for our next program “Digital Transformation for Researchers” until October 16 and dive deeper into the world of Digitization & Data Science.

 

CYTIVA virtual half-day forum

Thursday, 29 September 2022 04:22

Half-day virtual event from Cytiva: How biotech startups and translational researchers can prepare to bring innovative treatments to patients

Cytiva has invited several noteworthy colleagues from our industry to share their experience in an intimate online forum.

Join guests from THT Biomaterials (Vienna, AT), Charité (Berlin, DE), Prime Vector Technologies (Tübingen, DE), and a few Cytiva mentors who will discuss the challenges, triumphs, and key considerations for the development and delivery of novel therapies to patients.

In this virtual half-day forum, Cytiva invites industry leaders to share their experiences with overcoming obstacles and bringing novel therapies to patients. Join for guidance on what to expect on the translational journey along with how to avoid common pitfalls as you get started.
 
The program will be presented in two sessions with a 20-minute intermission. It will end with a roundtable discussion where you will have the chance to ask the experts your questions on how best to bridge basic research and clinical trials

When: Tuesday, 18 Oct, from 14:00 – 18:00 pm

More details: registration page - sign up and participate.

Even if your schedule conflicts, you are encouraged to register, as you will be sent a recording after the event.

31 Millionen Euro Budget stehen im Rahmen der Life Sciences Ausschreibung 2022 für Forschungs- und Entwicklungsprojekte und Klinische Studien zur Verfügung. Die Förderobergrenzen der reinen Zuschuss-Förderung liegen bei € 500.000,- im Falle von Unternehmensprojekten, bei € 1.000.000 im Falle von Klinischen Studien. Eine Antragstellung ist laufend bis längstens 29.12.2022 (12 Uhr) möglich.

https://www.ffg.at/ausschreibung/AustrianLifeSciences-2022

The European Researchers' Night "Life is Science - in a digital world" is an event that takes place simultaneously throughout Europe once a year and invites the public to get a taste of the everyday life of research institutions.

This year, the Austrian Center of Industrial Biotechnology (acib) and the St. Pölten University of Applied Sciences will jointly organize a hands-on event for young and old, for your school class and for the whole family.

Embark on an exciting journey through life science research on the topics of health & food, climate & environment, digital transformation and culture & community. Listen to exciting lectures, discuss current issues and try one or the other experiment yourself!

In Austria there are 3 different European Researcher's Night initiatives in Vienna, Salzburg, Innsbruck, St. Pölten and Graz as well as on the web.
The program in St. Pölten and Graz has the motto "Life is Science - in a digital world" and is organized by the Austrian Center for Industrial Biotechnology (acib) and the St. Pölten University of Applied Sciences. Details can be found here: https://www.lifeisscience.at


exploREsearch – from East to West in Austria

The program in Vienna, Salzburg, Innsbruck and on the web is themed “exploREsearch”. It is organized in cooperation with the Children's University, the University of Applied Arts Vienna, the University of Salzburg, the University of Innsbruck, the University of Natural Resources and Life Sciences Vienna (BOKU), Science Communication and bee produced. The details can be found on researchersnight.eu


research festival

In addition, the state of Lower Austria organizes the Research Festival Lower Austria in the Palais Niederösterreich in Vienna as part of the European Researchers' Night. Details can be found at forschungsfest.noe.gv.at


 

 

Life Sciences-Ausschreibung 2022 geöffnet

Tuesday, 13 September 2022 12:02

31 Millionen Euro Budget stehen im Rahmen der Life Sciences Ausschreibung 2022 für Forschungs- und Entwicklungsprojekte und Klinische Studien zur Verfügung. Die Förderobergrenzen der reinen Zuschuss-Förderung liegen bei € 500.000 im Falle von Unternehmensprojekten, bei € 1.000.000 im Falle von Klinischen Studien. Die Höhe des Zuschusses ist abhängig vom Organisationstyp und der Forschungskategorie. Eine Antragstellung ist laufend bis längstens 29.12.2022 (12 Uhr) möglich. Die Förderentscheidungen werden laufend zu fixen Stichtagen getroffen.

Weitere Informationen: https://www.ffg.at/ausschreibung/AustrianLifeSciences-2022

New ÖGMBT company members

Thursday, 08 September 2022 10:55

We welcome our new ÖGMBT Company Members: PHIO scientific GmbH, The Core Facilities of the University of Natural Resources and Life Sciences (BOKU), Ribbon Biolabs, VALIDOGEN, DirectSens, The Doctoral School in Microbiology and Ecosystem Science

 

    PHIO scientific GmbH is a high tech company from Munich, one of th e leading biotech-hubs in Europe. Our fully automatic, super compact microscopes and cutting-edge AI analysis platform allow for continuous imaging inside the incubator and tracking of cell growth, viability, motility and phenotype - on the fly. Our mission is to boost cell culture quality and cell-based research.

   The Core Facilities of the University of Natural Resources and Life Sciences (BOKU), Vienna centrally provide infrastructure and expertise from a broad range of different scientific disciplines, covering fields such as biochemical and biomolecular analyses, microscopy, bioinformatics, as well as bioprocess and food engineering. Our services are available for everyone: BOKU internal as well as external users, such as industry and other scientific organizations, are warmly welcome!

    Ribbon Biolabs mission is to serve the growing need for synthetic DNA as a fundamental component for innovation in biotechnology and biopharma. By providing our customers with rapid access to DNA molecules of sub-genomic size and in thousands of variants, we will empower them to create visionary solutions and to engineer novel products. Our revolutionary technology combines biology, computing and automation, allowing for fast and precise high throughput production of long DNA. Synthetic biology taken to the next level.

  VALIDOGEN - Pichia pastoris Protein Expression Excellence

VALIDOGEN, formerly known as VTU Technology, is a leading Austrian contract research and development company. VALIDOGEN offers UNLOCK PICHIA - the broadest toolbox and most versatile technology platform available for Pichia pastoris recombinant peptide/protein production. VALIDOGEN develops high performance expression strains and economically viable protein production processes for the manufacture of biopharmaceuticals, enzymes and various other recombinant proteins. Founded in 2008, the company emerged to a globally recognized player in the field of Pichia pastoris based protein expression.

  DirectSens was founded in 2013 as a BOKU Spinoff to convert scientific results into next generation biosensor solutions for the detection of carbohydrates. Since then, multiple products have been introduced to the market: The LactoSens has become the gold standard in Lactose testing, which is vital to the dairy industry. For the medical diagnostic field, continuous measurement systems detecting Glucose and Lactate are currently developed in collaboration with national and international partners. The fundamentally new architecture along with the flexibility of the technology enables DirectSens to provide its customers with reliable solutions for a wide range of applications.                            

     The Doctoral School in Microbiology and Ecosystem Science is a doctoral program that is unique in offering interdisciplinary training at the interfaces of microbiology, ecology, and environmental geosciences to address current challenges in the 21st century society, including the role of microbiomes, adaptation and resistance mechanisms, biogeochemistry, pollutant dynamics and nutrient fluxes in global change and for human, animal, plant, and environmental health. Our students are trained in the interdisciplinary environment at the Centre for Microbiology and Environmental Systems Science, which includes molecular microbiology, evolutionary and computational biology, and environmental sciences. Students have access to high-level infrastructure to study microbes, microbe-host interactions, and environmental processes at the forefront of fundamental and applied sciences.

 

 

The Life Science Career Paths series has new videos online from our events in May and June:

LabBuddy in May:  https://youtu.be/_NhSdPxpK7M

Job profile: "Entrepreneur in the life science field" by Koos van der Kolk (founder & CEO of LabBuddy)

Workshop: "Teaching skills - e-learning developer in the life science field" by Tineke Bijl (Head E-learning at LabBuddy)

DSM in June: https://youtu.be/7lFLgxta9y4

Job Profile: "Product Manager" by Luis Valenzuela (Global Product Manager at Gut Health DSM)

Workshop: "Let’s go Job Hunting - How to find the right company" by Claudia Huber-Newman (Senior Recruiter at DSM)

Check out our YouTube channel and watch the videos of all our Life Science Career Paths events!

See website for upcoming events: www.oegmbt.at/ueber-uns/oegmbt-ylsa#upcoming-events

As an YLSA volunteer you are part of an active team of early career researchers that are operating all over Austria! The team is organizing monthly career events, company visits and social events like the regulars’ table. Join the initiative now and boost your career: www.oegmbt.at/ueber-uns/oegmbt-ylsa

 

Page 1 of 2
  • FEBS Network News November
    The ÖGMBT has a very wide international network and is a member of several relevant scientific societies like FEBS. ÖGMBT members are automatically members of these societies and are entitled to benefits such as travel grants, short-term and long-term fellowships, Awards etc. Current calls and deadlines are published on our webpage and are sent to our members within the ÖGMBT newsletter.   ÖGMBT-YLSA (Young Life Scientists Austria) Young Life Scientists…
    29.11.2022,
  • FEMS - Get Involved bulletin – November 2022
    The new FEMS Get involved bulletin is out! Read the November issue with microbiology research, events and calls.   In this bulletin: FEMS Congress 9-13 July, 2023 in Hamburg, Germany #FEMSmicroBlog FEMS Journals Opportunities Board FEMS Grants   Deadlines: Meeting Organizer Grants: 1 December 2022 Research and Training Grants: 1 January 2023 Industry Placement Grants: 1 February 2023 Meeting Attendance Grants: 1 March 2023   The ÖGMBT has a very…
    29.11.2022,
  • Invitation to participate: open consultation for Strategic Research & Innovation Agenda (SRIA)
    Invitation to participate in an open consultation for the Strategic Research and Innovation Agenda (SRIA) in support for the European Partnership for Personalised Medicine, EP PerMed It is our pleasure to inform you that the open consultation to validate and receive input for the Strategic Research and Innovation Agenda (SRIA) in support for the European Partnership for Personalised Medicine, EP PerMed, is launched. The outcome of the online consultation will…
    28.11.2022,
  • ISIDORe preparedness calls for proposals
    ISIDORe preparedness calls for proposals Following its rapid research response calls for proposals dedicated to SARS-CoV-2  (still open) and Monkeypox virus (Pre-application deadline: 29 November 2022), ISIDORe (Integrated Services for Infectious Disease Outbreak Research) has launched its preparedness programme calls for proposals for free of charge access to the consortium facilities and services. To prevent future pandemics, and advance the development of the appropriate medical countermeasures, the ISIDORe preparedness programme…
    28.11.2022,
  • FEMS Affiliates Letter - November 2022
    As member of the ÖGMBT you are automatically also member of the Federation of European Microbiology Societies (FEMS). The FEMS Affiliates Letter of November 2022 has the following content: 1. Microbiology News and Events 2. FEMS Research 3. Policy Corner 4. Grants Corner 5. Opportunities 6. Extras     Important Dates: 3 October 2022: Abstract & Grants Submission open 1 December 2022: Industry & Innovation Award and Education Development Award Nomination Deadlines 1 January 2023:…
    25.11.2022,
  • FEMS - Get Involved bulletin – October 2022
    The new FEMS Get involved bulletin is out! Read the September issue with microbiology research, events and calls.   In this bulletin: FEMS Awards: Nominations until 1 December 2022 FEMS Journals Opportunities Board FEMS Grants   Deadlines: Meeting Organizer Grants: 1 December 2022 Research and Training Grants: 1 January 2023 Industry Placement Grants: 1 February 2023 Meeting Attendance Grants: 1 March 2023   The ÖGMBT has a very wide international…
    02.11.2022,
  • FEMS Affiliates Letter - October 2022
    As member of the ÖGMBT you are automatically also member of the Federation of European Microbiology Societies (FEMS). The FEMS Affiliates Letter of October 2022 has the following content:   1. Microbiology News and Events 2. FEMS Research 3. Policy Corner 4. Grants Corner 5. Opportunities     Important Dates: 3 October 2022: Abstract & Grants Submission open 1 January 2023: Registration Opens 1 February 2023: Abstract & Grants Submission deadline    
    02.11.2022,
  • "HGSC - Helicobacter genomics, signaling and carcinogenesis” conference 2023
    "HGSC - Helicobacter genomics, signaling and carcinogenesis” conference from 02 to 05 December 2023 at the beautiful Castle Hirschberg in Beilngries (Bavaria, Germany). The HGSC conference is a high profile meeting that brings together established researchers and young scientists to share their latest data and vision in the field of Helicobacter. Sessions are organized on the key disciplines of genomics, pathogen evolution, pathogen-host interactions, signal transduction, immuno-oncology as well as translational…
    25.10.2022,
  • Webinar: Moving Ahead on Gender Equity: A Chemistry Perspective
    The International Union of Pure and Applied Chemistry is the global organization that provides objective scientific expertise and develops the essential tools for the application and communication of chemical knowledge for the benefit of humankind and the world. In 2019 IUPAC entered its second century, providing an opportunity to launch initiatives to create a more diverse and inclusive community. This webinar offers an overview, some insights and progress on this…
    24.10.2022,
  • FEMS Research Bulletin - no. 001
    As member of the ÖGMBT you are automatically also member of the Federation of European Microbiology Societies (FEMS). See the FEMS Research Bulletin - no. 001 with the latest top-quality science and developments from the FEMS Journals.   Important Dates: 3 October 2022: Abstract & Grants Submission open   Start of 2023: Registration Opens   1 February 2023: Abstract & Grants Submission deadline  
    14.10.2022,
  • New ÖGMBT company member
    We welcome our new ÖGMBT Company Member: Ludwig Boltzmann Gesellschaft Career Center (LBG-CC)    LBG Career Center – We care for Pre- & Post-Docs We support (young) researchers in Austria in achieving their individual career goals – in or outside of academia. Contact us for a career chat, join our workshops or special programs and design your own unique career path! We empower you to enhance your knowledge and skills…
    03.10.2022,
    by
  • New ÖGMBT company members
    We welcome our new ÖGMBT Company Members: PHIO scientific GmbH, The Core Facilities of the University of Natural Resources and Life Sciences (BOKU), Ribbon Biolabs, VALIDOGEN, DirectSens, The Doctoral School in Microbiology and Ecosystem Science       PHIO scientific GmbH is a high tech company from Munich, one of th e leading biotech-hubs in Europe. Our fully automatic, super compact microscopes and cutting-edge AI analysis platform allow for continuous imaging…
    08.09.2022,
    by
  • Erklärvideo zu Totimpfstoffen gegen COVID-19
    Das neue Erklärvideo von Open Science "SARS-CoV-2: Totimpfstoffe" ist fertig - rechtzeitig zum Start der Impfung mit dem Proteinimpfstoff von Novavax! Das Video, das in Kooperation mit dem Doktoratskolleg RNA-Biologie und der FH Campus Wien entstanden ist, erklärt, wie inaktivierte Ganzvirus- und Proteinimpfstoffe gegen COVID-19 hergestellt werden, was sie beinhalten und wie sie wirken.    
    02.03.2022,
  • Labbuddy - Training lab teaching
    We developed a training on teaching in the lab, in which we will provide teachers with tips and tricks that will help them inspire student learning in the lab. Laboratory course teaching fundamentals Teaching seems easy…….. ………until the moment you need to teach! Teaching is a true profession, but everyone can learn how to teach. Do you need to teach because of your Ph.D. study, or are you a teacher…
    27.01.2022,
    by
  • Open Call for Applications: 4 Fellowships 4 Entrepreneurs 2022
    Do you have an entrepreneurial idea that you want to develop under the guidance of experts? Are you ready to sound out your entrepreneurial spirit? Then the LBG Career Center might have the right program for you! Within the 4 Fellowships 4 Entrepreneurs program, you will build foundational knowledge about entrepreneurship, receive support on your journey to launching your ideas, and start on the path to becoming an entrepreneur.Throughout 9 months,…
    18.01.2022,
    by
  • FEBS Junior Sections Talk Series 2022
    FEBS Junior Sections Talk Series 2022 We have planned a series of monthly talks for 2022, alternating academic and career topics, each organized by a Junior Section from a different country. 13th January. Academic. Organized by Junior-GBM (the Junior Section of the German Society, GBM). A talk by Dr Andreas Schlundt, from Goethe University Frankfurt, on “The roles of sequence, structure and dynamics for specific RNA-recognition by proteins". Watch the recorded…
    18.01.2022,
    by
  • Chemiereport 8/21
    Chemiereport 8/12- the 8th edition of Chemiereport is out featuring news from life science world in Austria and most importantly covering article under the title  ”ÖGMBT presents career opportunities in the Life Sciences”.  In the article ÖGMBT interim manager Andrea Bauer speaks on all the ways ÖGMBT and ÖGMBT-YLSA explore possibilities for young life scientists in the field. More so by organizing variety of career events, presenting job profiles on…
    29.12.2021,
    by
  • IUBMB grants
    IUBMB grants- There is variety of travel and fellowship grants for young researchers from International Union of Biochemistry and Molecular Biology with upcoming deadlines.  Check it out here.
    04.11.2021,
    by
  • FEBS-IUBMB-ENABLE 2022 Symposium – a PhD and Postdoc meeting
    FEBS-IUBMB-ENABLE are now looking for an academic institution (either a university or a research institution) in Europe with a strong research background in molecular life sciences and an active PhD community to host the November 2022 conference. This event will be organized by a committee of young researchers belonging to the four ENABLE institutions (core institutions, as listed above) plus the selected host institution (associated institution). It will be organized…
    25.08.2021,
    by
  • FEBS junior initiative
    To bring together young scientists from all over Europe, the junior sections of the ÖGMBT (Austria), SIB (Italy), SEBBM (Spain) and GBM (Germany) have collaborated with FEBS to establish a platform for exchange within the FEBS Network. For this, FEBS has created an open Room for the Junior Sections of FEBS Constituent Societies. All young members from the FEBS societies are welcome to sign up to the FEBS Network and become a member of the room using the following…
    25.08.2021,
    by
  • live Webinar – 10 hints for your job search and application
     InvitationAs in last minute it was impossible for me to attend the CARLiS in Bratislava I have prepared a special webinar for the participants of Bratislava and I invite you to join the live Zoom-webinar. No registration necessary, free of charge.Tuesday 29th of November, 5 – 6 pmFollow the Zoom-Link or if it doesn’t work, copy...
    28.11.2022,
  • Tödlicher Stoff
    Es ist schon absurd, dass ein einfaches Stück Stoff Massen in Aufruhr bringen kann.… Sie würde ebenfalls lieber ein Tuch tragen, wie viele andere Frauen hier. Ein Tuch locker um die Ohren legen, sieht stilvoller aus als wie eine Wollmütze. Scheinbar ist der kalte Luftzug auch anderen unangenehm. Dieses einfache Kleidungsstück ist praktisch, ü...
    22.11.2022,
  • Principal Scientist Bioprocess Development (f/m/d)
    Principal Scientist Bioprocess Development (f/m/d) Boehringer Ingelheim RCVDer Beitrag Principal Scientist Bioprocess Development (f/m/d) erschien zuerst auf Jobbörse und Netzwerk für Naturwissenschaftler /-innen....
    16.11.2022,
  • Ist ein dauerhafter Frieden auf der ganzen Welt möglich
    Jeder träumt insgeheim von einer besseren Zukunft, von einem Leben, in dem jeder hat, was er braucht, um glücklich, gesund und zufrieden zu sein. Von einem Leben in Freiheit, in dem die Menschen, egal welcher Hautfarbe oder Religion, welchen Berufs oder welchen Geschlechts, einander vertrauen, miteinander lachen, sich aufeinander verlassen können....
    15.11.2022,
  • (Trainee) Lab Scientist Research Immunology (f/m/d)
    (Trainee) Lab Scientist Research Immunology (f/m/d) Boehringer Ingelheim RCVDer Beitrag (Trainee) Lab Scientist Research Immunology (f/m/d) erschien zuerst auf Jobbörse und Netzwerk für Naturwissenschaftler /-innen....
    15.11.2022,
  • CMC Senior Projektleiter*in Contract Manufacturing Business (w/m/d)
    CMC Senior Projektleiter*in Contract Manufacturing Business (w/m/d) Boehringer Ingelheim RCVDer Beitrag CMC Senior Projektleiter*in Contract Manufacturing Business (w/m/d) erschien zuerst auf Jobbörse und Netzwerk für Naturwissenschaftler /-innen....
    12.11.2022,
  • Labormitarbeiter*in/ Laborant*in Inprozess-Kontrolle Schwerpunkt Chemische Analytik
    Labormitarbeiter*in/ Laborant*in Inprozess-Kontrolle Schwerpunkt Chemische Analytik DSM Austria GmbHDer Beitrag Labormitarbeiter*in/ Laborant*in Inprozess-Kontrolle Schwerpunkt Chemische Analytik erschien zuerst auf Jobbörse und Netzwerk für Naturwissenschaftler /-innen....
    12.11.2022,
  • CMC Projektleiter*in Contract Manufacturing Business (w/m/d)
    CMC Projektleiter*in Contract Manufacturing Business (w/m/d) Boehringer Ingelheim RCVDer Beitrag CMC Projektleiter*in Contract Manufacturing Business (w/m/d) erschien zuerst auf Jobbörse und Netzwerk für Naturwissenschaftler /-innen....
    12.11.2022,
  • Expert Human Pharma Communications (f/m/d)
    Expert Human Pharma Communications (f/m/d) Boehringer Ingelheim RCVDer Beitrag Expert Human Pharma Communications (f/m/d) erschien zuerst auf Jobbörse und Netzwerk für Naturwissenschaftler /-innen....
    11.11.2022,
  • (Associate) Principal Scientist – Collaborative Medicinal Chemistry (f/m/d)
    (Associate) Principal Scientist – Collaborative Medicinal Chemistry (f/m/d) Boehringer Ingelheim RCVDer Beitrag (Associate) Principal Scientist – Collaborative Medicinal Chemistry (f/m/d) erschien zuerst auf Jobbörse und Netzwerk für Naturwissenschaftler /-innen....
    11.11.2022,